company background image
GXI logo

Gerresheimer SWX:GXI Stock Report

Last Price

CHF75.60

Market Cap

CHF3.5b

7D

0%

1Y

0%

Updated

26 Mar, 2024

Data

Company Financials +

GXI Stock Overview

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

GXI fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Gerresheimer AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Gerresheimer
Historical stock prices
Current Share Price€75.60
52 Week High€0
52 Week Low€0
Beta0.91
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Change0%
5 Year Change0%
Change since IPO40.26%

Recent News & Updates

Recent updates

Shareholder Returns

GXICH Life SciencesCH Market
7D0%7.4%0.2%
1Y0%0.5%4.3%

Return vs Industry: GXI matched the Swiss Life Sciences industry which returned 0.6% over the past year.

Return vs Market: GXI underperformed the Swiss Market which returned 4.4% over the past year.

Price Volatility

Is GXI's price volatile compared to industry and market?
GXI volatility
GXI Average Weekly Movement0%
Life Sciences Industry Average Movement5.5%
Market Average Movement3.4%
10% most volatile stocks in CH Market7.7%
10% least volatile stocks in CH Market1.8%

Stable Share Price: GXI has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GXI's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
186411,660Dietmar Siemssenhttps://www.gerresheimer.com

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.

Gerresheimer AG Fundamentals Summary

How do Gerresheimer's earnings and revenue compare to its market cap?
GXI fundamental statistics
Market capCHF3.50b
Earnings (TTM)CHF113.17m
Revenue (TTM)CHF1.94b

30.9x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GXI income statement (TTM)
Revenue€1.99b
Cost of Revenue€1.39b
Gross Profit€597.31m
Other Expenses€481.19m
Earnings€116.13m

Last Reported Earnings

Nov 30, 2023

Next Earnings Date

Apr 11, 2024

Earnings per share (EPS)3.36
Gross Margin30.01%
Net Profit Margin5.83%
Debt/Equity Ratio66.5%

How did GXI perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

36%

Payout Ratio

Does GXI pay a reliable dividends?

See GXI dividend history and benchmarks
When do you need to buy GXI by to receive an upcoming dividend?
Gerresheimer dividend dates
Ex Dividend DateJun 06 2024
Dividend Pay DateJun 10 2024
Days until Ex dividend72 days
Days until Dividend pay date76 days

Does GXI pay a reliable dividends?

See GXI dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.